144 related articles for article (PubMed ID: 20579387)
1. Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas.
Bao G; Qiao Q; Zhao H; He X
World J Surg Oncol; 2010 Jun; 8():52. PubMed ID: 20579387
[TBL] [Abstract][Full Text] [Related]
2. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
3. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
[TBL] [Abstract][Full Text] [Related]
4. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of hmgb1 expression in human gastric cancer.
Zhang J; Zhang R; Lu WW; Zhu JS; Xia LQ; Lu YM; Chen NW
Int J Immunopathol Pharmacol; 2014; 27(4):543-51. PubMed ID: 25572734
[TBL] [Abstract][Full Text] [Related]
9. High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas.
Suren D; Arda Gokay A; Sayiner A
J BUON; 2018; 23(2):422-427. PubMed ID: 29745087
[TBL] [Abstract][Full Text] [Related]
10. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
13. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
15. [Expression of HMGB1 protein in laryngeal squamous cell carcinoma and its clinical significance].
Liu Y; Xie CL; Qiu YZ; Tian YQ; Zhang X; Huang DH; Zhou XJ; Tan PQ; Yu CY; Qi L; Li B; Xiao JY
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):132-6. PubMed ID: 22780932
[TBL] [Abstract][Full Text] [Related]
16. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.
Seo HM; Chang YS; Joo SH; Kim YW; Park YK; Hong SW; Lee SH
J Surg Oncol; 2009 Mar; 99(3):143-7. PubMed ID: 19117018
[TBL] [Abstract][Full Text] [Related]
20. CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer.
Ha SY; Do IG; Lee J; Park SH; Park JO; Kang WK; Choi MG; Lee JH; Bae JM; Kim S; Kim KM; Sohn TS
Ann Surg Oncol; 2014 Apr; 21(4):1099-106. PubMed ID: 24306658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
